Enrico Coiera, PhD

Speaker: Enrico Coiera, PhD, at Australian Institute of Health Innovation

Date: April 29, 2021 - 6:30PM

Trained in medicine and with a computer science PhD in Artificial Intelligence (AI), Dr. Coiera has a research background in both industry and academia and a strong international research reputation for his work on decision support and communication processes in biomedicine. Dr. Coiera spent 10 years at the prestigious Hewlett-Packard Research Laboratories in Bristol UK where he led numerous health technology projects. He has overseen the development and trial of multiple eHealth interventions, including the Healthy.me consumer system as well as clinical decision support systems. Healthy.me technologies underpin a new US health startup called Healthbanc. His textbook Guide to Health Informatics is in its 3rd edition, is widely used internationally, and is translated into several languages. Dr. Coiera has won a number of prestigious awards including the 2015 International Medical Informatics Association (IMIA) François Grémy Award for Excellence and the 2011 UNSW Inventor of the year (Information and Communication Technology) for a literature-based computational discovery system. He was elected Foundation Fellow and first President of the Australian College of Health Informatics, is a foundation member of the International Academy of Health Sciences Informatics, and an International Fellow of the American College of Medical Informatics. Dr. Coiera has also held key appointments on boards, councils and editorial positions on international journals including Associate Editor of the journal ‘Artificial Intelligence in Medicine’.

Publications

Zhang A, Teng L, Alterovitz G. An explainable machine learning platform for pyrazinamide resistance prediction and genetic feature identification of Mycobacterium tuberculosis. Journal of the American Medical Informatics Association : JAMIA 2020.

Geva A, Stedman JP, Manzi SF, Lin C, Savova GK, Avillach P, Mandl KD. Adverse drug event presentation and tracking (ADEPT): semiautomated, high throughput pharmacovigilance using real-world data. JAMIA open 2020.

Börcsök J, Sztupinszki Z, Bekele R, Gao SP, Diossy M, Samant AS, Dillon KM, Tisza V, Spisák S, Rusz O, Csabai I, Pappot H, Frazier ZJ, Konieczkowski DJ, Liu D, Vasani N, Rodrigues JA, Solit DB, Hoffman-Censits JH, Plimack ER, Rosenberg JE, Lazaro JB, Taplin ME, Iyer G, Brunak S, Lozsa R, Van Allen EM, Szüts D, Mouw KW, Szallasi Z. Identification of a synthetic lethal relationship between nucleotide excision repair (NER) deficiency and irofulven sensitivity in urothelial cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020.

Gokuldass A, Draghi A, Papp K, Borch TH, Nielsen M, Westergaard MCW, Andersen R, Schina A, Bol KF, Chamberlain CA, Presti M, Met Ö, Harbst K, Lauss M, Soraggi S, Csabai I, Szállási Z, Jönsson G, Svane IM, Donia M. Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8 T Cells in Non-Melanoma Cancers Compared to Melanoma. Cancers 2020.

Perera G, Rijnbeek PR, Alexander M, Ansell D, Avillach P, Duarte-Salles T, Gordon MF, Lapi F, Mayer MA, Pasqua A, Pedersen L, van Der Lei J, Visser PJ, Stewart R. Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case-control study using European electronic health records. BMJ open 2020.